Reference
Salvia AL, et al. Capecitabine plus temozolomide in well- or moderately-differentiated primary atypical neuroendocrine tumours - single-centre experience of two cases. Endokrynologia Polska 70: 380-383, No. 4, 2019. Available from: URL: http://doi.org/10.5603/EP.a2018.0076
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1796, 35 (2020). https://doi.org/10.1007/s40278-020-76322-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-76322-z